RecruitingNCT03810768

Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness

Metabolomics Pilot Study on Postoperative Intensive Care Acquired Muscle Weakness (MIRACLE-I Study)

Sponsor

Technical University of Munich

Enrollment

20 participants

Start Date

Sep 2, 2022

Study Type

OBSERVATIONAL

Conditions

Muscle Weakness Metabolomics Critical Illness Critical Care Intensive Care (ICU) Myopathy Critical Illness Myopathy Critical Illness Polyneuropathy

Summary

In this mono-center pilot trial, surgical patients who are at high risk to be admitted to intensive care will be screened and asked for participation. We are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing. Aim of the study is to investigate (1) changes of the blood metabolome in patients with ICUAW (intensive care unit acquired weakness) and (2) identify metabolic components who are responsible for ICUAW or can be used as marker for ICUAW.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with critical care, critical illness, and other related conditions. The study is currently recruiting participants at 3 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.